SCHEMBL4627741

SCHEMBL4627741

CCOc1ccc(CC)c(Cc2c[nH]c(-c3nc(Cc4c(CC)cc(OCc5ccccc5)cc4CC)c[nH]3)n2)c1CC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPYD Q12882 1/20 0.36
GABRA1 P14867 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35
GABRA3 P34903 1/20 0.35
GABRA2 P47869 1/20 0.35
JAK2 O60674 1/20 0.35
JAK3 P52333 1/20 0.35
AOC3 Q16853 1/20 0.35
KDM4E B2RXH2 3/20 0.34
LMNA P02545 1/20 0.34
MAPK14 Q16539 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.33
NSD2 O96028 1/20 0.33
ABL1 P00519 1/20 0.33
PPARG P37231 1/20 0.33
RIN1 Q13671 1/20 0.33
NCOR2 Q9Y618 1/20 0.33
MAPK1 P28482 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4627742 0.86 GABRA1 (0.35) DPYDGABRA1GABRG2GABRB3GABRA5
SCHEMBL4629064 0.78 HSD17B10 (0.33) KDM4EALDH1A1
SCHEMBL2100697 0.73 DPYD (0.41) DPYDL3MBTL1NSD2ABL1PPARG
SCHEMBL4630242 0.73 TAAR1 (0.54) AOC3KDM4ELMNAMAPK14L3MBTL1
SCHEMBL4630237 0.70 TAAR1 (0.56)
SCHEMBL2626859 0.70 HRH3 (0.51) L3MBTL1NSD2ABL1PPARGRIN1
SCHEMBL954171 0.69 TAAR1 (0.58) AOC3LMNAMAPK14L3MBTL1MAPK1
SCHEMBL954953 0.69 TAAR1 (0.60) DPYDLMNAL3MBTL1NSD2ABL1
SCHEMBL2103538 0.68 MAPT (0.33) AOC3L3MBTL1MAPT
SCHEMBL2102243 0.64 ALOX15 (0.36) KDM4EL3MBTL1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1981880-A2 USE OF 4-IMIDAZOLE DERIVATIVES FOR CNS DISORDERS F.HOFFMANN-LA ROCHE AG (CH) 2008-10-22 EP claimed
WO-2007085556-A2 USE OF 4-IMIDAZOLE DERIVATIVES FOR CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2007-08-02 WO claimed
EP-1981880-A2 USE OF 4-IMIDAZOLE DERIVATIVES FOR CNS DISORDERS F.HOFFMANN-LA ROCHE AG (CH) 2008-10-22 EP disclosed
WO-2007085556-A2 USE OF 4-IMIDAZOLE DERIVATIVES FOR CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2007-08-02 WO disclosed